BioSpace News Archive

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, will have multiple scientific data presentations at the European Society for Medical Oncology Virtual Congress 2021, held on September 16-21.

InnoCare Pharma, a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced 2021 half year results which ended on June 30, 2021.

Junshi Biosciences announced that the United States Food and Drug Administration, alongside the Office of the Assistant Secretary for Preparedness and Response, has resumed the shipment and distribution of etesevimab and bamlanivimab administered together, according to the company’s global partner Eli Lilly and Company.